Cell aging: when growth stimuli meet cell cycle arrest

Published Date: 08 Mar 2023

A new review article titled "Cellular Aging: When Growth Stimuli Meet Cell Cycle Arrest" is published in Aging.

Read Full News

Latest News

Recurrent UTIs Within 6 Months May Signal Cancer Risk

Individuals presenting with repeated UTIs experience longer diagnostic delays and poorer outcomes than those presenting with hematuria.

Acute Liver Failure: 5 Things to Know

Acute liver failure requires rapid recognition and intervention, with delays associated with significantly increased mortality risk.

New Data: US Psilocybin Use Reaches 8 Million

About 8 million people in the US use psilocybin, which is linked to depression, alcohol use disorder, cannabis use, and prescription drug misuse, a new study shows.

What’s Really Going on in Aging Tendons and Ligaments

Staying active your whole life means avoiding injury. Connective tissue may not get the same love muscles do but these strategies can mitigate risk.

Genotype-Guided SSRI Prescribing Offers Mixed Results

Use of genotype-guided SSRI shows no symptom improvement at 3 months in people with depression but is linked to higher remission rates at 6 months.

CGRP Inhibitors for Migraine Linked to Reduced Glaucoma Risk

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for glaucoma than the use of non-CGRP inhibitors, a new study shows.

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Todays Updates

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Non-Factor Therapies in Hemophilia: Cutting-Edge Approaches to Individualize Care

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Precision Medicine in mHSPC: Integrating Novel Biomarkers, Imaging, and Emerging Targeted Agents

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Accelerating the Evidence-Based Integration of Menin Inhibitors Into R/R AML Care: A Live Expert TheraTalk

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

Frontline Decisions in Transplant-Ineligible Multiple Myeloma: Evaluating Quadruplet Therapy

GuCS: Genitourinary Cancers Symposium

GuCS Video Pearls: Video Pearls from the Genitourinary Cancers Symposium

GuCS Future Focus: Future Focus from the Genitourinary Cancers Symposium

Latest News

Individuals presenting with repeated UTIs experience longer diagnostic delays and poorer outcomes than those presenting with hematuria.

Acute liver failure requires rapid recognition and intervention, with delays associated with significantly increased mortality risk.

About 8 million people in the US use psilocybin, which is linked to depression, alcohol use disorder, cannabis use, and prescription drug misuse, a new study shows.

Staying active your whole life means avoiding injury. Connective tissue may not get the same love muscles do but these strategies can mitigate risk.

Use of genotype-guided SSRI shows no symptom improvement at 3 months in people with depression but is linked to higher remission rates at 6 months.

The use of calcitonin gene-related peptide (CGRP) inhibitors to treat adults with migraine is linked to a 25% lower risk for glaucoma than the use of non-CGRP inhibitors, a new study shows.

News All Time

Tegoprazan TRIUMpHs Over PPI For Erosive Esophagitis

Tegoprazan is superior to the proton pump inhibitor lansoprazole for healing erosive esophagitis as early as week 2, but one expert finds these results underwhelming.

Q&A: Progress in Thwarting ‘Chemobrain’

Recent trials suggest that simple steps during chemotherapy — including moderate exercise and a daily ibuprofen — may lessen treatment-related cognitive symptoms.

Second Cancer Rates Vary Widely Among Survivors

Not all cancer survivors face the same likelihood for a second cancer. New data show striking differences by age, cohort, and initial diagnosis.

A Verdict on Low-Dose Lithium for Cognitive Preservation?

Researchers hoped results from the latest trial on low-dose lithium would settle the question of lithium’s potential to preserve cognitive function. It didn’t.

Digital NHS Risks Leaving Older Patients Behind

Older people lack the skills, devices, or support to book GP appointments online — and many are giving up on trying.

FDA Authorizes First Fruit-flavored E-cigarettes in US Amid Political Pressure

The U.S. Food and Drug Administration on Tuesday allowed the marketing of fruit-flavored e-cigarettes ⁠in a first authorization of non-tobacco-flavored vaping products, amid...

What About the Bone Effects of GLP-1 Receptor Agonists?

GLP-1 receptor agonists do not appear to increase fracture risk at diabetes doses, but caution may be needed with higher obesity doses and rapid weight loss

Cervical Cancer Screening Gaps Persist After 65 Years of Age

Most women requiring continued cervical cancer screening — including those at high risk — do not continue screening after 65 years of age.

CME-Based Board Certification Path Gains Ground

A CME-based certification option is attracting increasing interest as physicians and specialty groups weigh alternatives to traditional maintenance-of-certification models.

Sudden Headache During Sexual Activity: A Vascular Cause?

Headaches during sexual activity require prompt evaluation to exclude subarachnoid hemorrhage or reversible cerebral vasoconstriction syndrome.

Novel Cell Therapy Shows Promise in Resistant TLE

A novel cell therapy is safe and effective in patients with drug-resistant mesial temporal lobe epilepsy and could eventually offer an alternative intervention.

AI Scribes’ Notes Show Quality Gaps vs Human Output

In an assessment of five scenarios in primary care, clinical notes generated by AI exhibited lower quality scores than those produced by human clinicians.

Budesonide Should Be Taken Continuously for EoE Remission

Research favors continuous treatment for eosinophilic esophagitis vs intermittent therapy, underlining the need to counsel patients on optimal adherence.

Robotic Colonoscopy System Poised for the Clinic

A first-in-human trial of a robotic colonoscopy shows the system can perform all functions of a colonoscope with promising results and less wear and tear on colonoscopists.

UK Leads Global Bird Flu Vaccine Trial

The UK will provide three-quarters of the volunteers for an international mRNA vaccine trial against H5N1 bird flu, with 26 recruitment sites across the country.

Acetylcholinesterase Inhibitors May Lower Risk for Delirium

The continuous use of acetylcholinesterase inhibitors may reduce the risk for delirium in patients with dementia.

Recommended News For You

Can taking vitamin D supplements every day lower the mortality rate from cancer?

The most precise research tools for the deadliest blood cancer have been developed.

Cancer Patients Are Receiving More and More Stupid Immunotherapy.

Cancer Patients' Depression May Be Helped by Psilocybin.

Childhood cancer survivors face new health problems later in life, study shows

Study finds higher breast cancer rates in areas with more air pollution

Effective Intralesional Melanoma Therapy May Involve Systemic Effects.

Recommended Articles For You

Toripalimab + Nab-Paclitaxel in PD-L1+ TNBC: Phase 3 TORCHLIGHT Trial Results 

Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment 

How Prevident is Revolutionizing Oral Care 

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer

2.

CDC Alerts on Dramatic Rise in Human Parvovirus B19

3.

Aspirin for CRC Risk Reduction May Benefit Unhealthy People Most

4.

Scientists discover the 'roadmap' that aggressive cancer uses to spread

5.

ASCO: Vepdegestrant ups survival in ER+, HER2− advanced breast cancer with ESR1 mutations

1.

The Next Generation of Precision: How Multi-Specific Antibodies are Redefining Oncology's Future - A 2025 Review

2.

CAR-T Cell Therapy for B-Cell Acute Lymphoblastic Leukemia: A Comprehensive Review

3.

The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects 

4.

Exploring Innovative Solutions for Infantile Hemangioma Treatment

5.

Case Study: The Role of Machine Learning in the Detection of Skin Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC

2.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

3.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

5.

Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot